Aug 11, 2023, 15:20
Take a look at new work uncovering novel aspects of MHC degradation with exciting therapeutic implication to target tumor immune evasion – The Mark Foundation for Cancer Research
Take a look at new work uncovering novel aspects of MHC degradation with exciting therapeutic implication to target tumor immune evasion. We are proud to be a major sponsor of this work with a Mark Foundation ASPIRE award led by Jun Wang and Iannis Aifantis.
Out today Cell our latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially important for T cell recognition in cancer. A great collaboration with Jun Wang and NYU Grossman School of Medicine.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 26, 2024, 16:39
Sep 26, 2024, 16:34
Sep 26, 2024, 16:21
Sep 26, 2024, 16:19
Sep 26, 2024, 16:07
Sep 26, 2024, 15:44
Sep 26, 2024, 15:41
Sep 26, 2024, 15:39